Stifel Nicolaus analyst Daniel Arias maintained a Hold rating on Bruker (BRKR – Research Report) today and set a price target of $57.00. The ...

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm expects the life science tools and diagnostics ...

Designed for the analysis of chemical processes by NMR, InsightMR is the ideal solution for both industrial and academic scientists studying or optimizing reactions. InsightMR’s two components ...

Bruker's minispec Whole Body Composition Analyzer based on TD-NMR provides a precise method for measurement of lean tissue, fat and fluid in living mice and rats. This body composition analyzer ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to the ...

The Chiefs quarterback was in a suit, which wasn't surprising at all. The surprising part is that it was a GREEN suit that very much looked like it was a similar shade to the colors worn by the ...

After hours: February 13 at 5:04:50 PM EST Loading Chart for BRKR ...

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

The green crocodile, complete with its white detailing and striking red mouth, captures attention and provides a visual cue that stands out in the crowded fashion industry. Additionally, the unique ...

Upgrading biogas to valuable solid carbon can potentially lead to negative CO 2 emissions with long-term carbon storage but faces substantial thermodynamic and kinetic limits using a single reactor.